Schedule 13D ownership disclosure
PROVECTUS PHARMACEUTICAL INCORPORATED
Common Stock, par value $0.001 per share · CUSIP: 74373P108
Event date: 2025-12-02
- Filing-level shares
- 25,220,549.00
- Percent of class
- 5.67%
- Dominic RodriguesReported CIK 0001703719
Shares: 25,220,549.00 · Class: 5.67%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-25-026550
- Form type
- SCHEDULE 13D
- Filer
- PROVECTUS BIOPHARMACEUTICALS, INC.
- CIK
- CIK 315545
- Filed
- Dec 08, 2025
- Reporting period
- Dec 02, 2025
- Description
- Schedule 13D beneficial ownership